Skip to textbook content
Doctor’s PassportTextbook
TopicsAll topics

Loading topic navigation…

Textbook navigation
TopicsAll topics

Loading topic navigation…

Educational draft · awaiting clinical reviewUse Rapid for revision, not patient-care decisions. Check current national and local guidance and the BNF or BNFC before acting.

Hypopituitarism

Endocrinology and metabolism · UK scope · Sources checked 27 Aug 2026 · Clinical review pending

RapidFull

Synopsis

Identify loss of individual or multiple pituitary axes, protect cortisol before other replacement, and provide lifelong cause-specific hormone, fertility, water-balance and emergency follow-up.

  • Hypopituitarism may follow pituitary or hypothalamic tumour, surgery, radiotherapy, apoplexy, head injury, subarachnoid haemorrhage, infiltrative disease, infection, genetic disease or immune checkpoint therapy.
  • Hormone loss can be isolated, sequential or complete; ACTH deficiency is the immediately dangerous component and may present with normal potassium because aldosterone remains renin-angiotensin regulated.
  • In central hypothyroidism, free T4 is low with TSH that is low, normal or only mildly raised; TSH cannot be used as the levothyroxine dose target.
  • Secure cortisol secretion or give glucocorticoid cover before thyroid replacement, because increasing thyroid hormone in an ACTH-deficient patient can precipitate adrenal crisis.
  • Low gonadotrophins with low sex hormone causes amenorrhoea, infertility, low libido, erectile dysfunction, hot flushes and bone loss; replacement and fertility induction have different goals and regimens.
  • Random growth hormone is not diagnostic because secretion is pulsatile; adults usually require appropriate dynamic testing after other pituitary deficits have been replaced.
  • Posterior pituitary disease causes arginine vasopressin deficiency with polyuria and thirst; desmopressin can cause fatal hyponatraemia if fluid intake and sodium are not managed.
  • Patients with ACTH deficiency need daily adherence, sick-day dosing, an NHS Steroid Emergency Card, emergency injection education and procedure-specific cover.

Key red flags

Shock, recurrent vomiting, severe weakness, altered consciousness or hypoglycaemia in a patient with pituitary disease demands immediate hydrocortisone and resuscitation for possible adrenal crisis.

Sudden headache with visual or ocular-motor change requires the pituitary apoplexy pathway rather than routine hormone adjustment.

Rapid visual decline or new bitemporal field loss suggests compressive sellar progression and needs urgent MRI and specialist assessment.

Polyuria with hypernatraemia, inability to access water or impaired consciousness is a water-balance emergency requiring monitored fluid and endocrine care.

Severe hyponatraemia, confusion or seizure while taking desmopressin suggests water intoxication and needs immediate drug, fluid and sodium management.

Investigation priorities

01
Eight to nine am cortisolFirst step

Screen the ACTH-cortisol axis before elective replacement or dynamic testing.

Management branches

MAPAxis-by-axis assessment

Pituitary disease or treatment creates symptoms compatible with partial or complete hormone loss.

  1. Identify urgent cortisol, visual, neurological and sodium threats before arranging non-urgent dynamic investigations.
  2. Measure paired target and trophic hormones, document exogenous steroids and hormone therapies, and obtain dedicated pituitary imaging where cause is unknown.
  3. Classify each axis as intact, deficient, uncertain or confounded rather than applying a single diagnosis of panhypopituitarism.
  4. Agree replacement sequence, definitive tumour treatment and a timed reassessment plan through the pituitary multidisciplinary service.

Key medicines

HydrocortisoneNICE first-choice replacement is 15 to 25 mg orally each day in two to three divided doses, with the larger dose earlier.Provide sick-day and emergency injection measures; monitor weight, blood pressure, glucose and bone, and remember that fludrocortisone is not routinely required centrally.
LevothyroxineBegin after cortisol safety is established and titrate an individual once-daily dose to free T4, symptoms, age and cardiovascular status.Do not reduce solely because TSH becomes suppressed; check adherence, interactions and free T4 timing, and avoid precipitating untreated adrenal failure.
Open full textbook →Answer 2 questions
Sources and review status5 sources · checked 27 Aug 2026 · clinical review pending+
Sources

Sources and review status

National guidance is shown before implementation-dependent detail. Typical adult dose examples remain subject to patient factors, contraindications and the live BNF or specialist protocol. Source check completed 27 Aug 2026; clinical approval remains outstanding.

  • NICE NG243 Adrenal insufficiency recommendationsSecondary adrenal replacement, stress dosing, crisis and follow-up.
  • NICE BNF Adrenal insufficiencyCurrent British replacement and emergency prescribing summary.
  • Society for Endocrinology clinical guidanceUK pituitary, adrenal and inpatient water-balance guidance.
  • Leeds Pituitary Centre handbookNHS pituitary diagnosis, replacement, visual and multidisciplinary follow-up.
  • CUH steroid replacement guidanceNHS practical adherence, travel, emergency card and sick-day support.

Editorial contact: Doctor’s Passport editorial team. Source-check date is separate from clinical approval. Report a content problem · Content changes

Authoring stateRapid draftClinical stateAwaiting reviewJurisdictionUnited Kingdom